Accord Logo

Intended for UK patients and members of the public

PIL- Posaconazole Accord 100 mg gastro-resistant tablets (PLGB 20075/1439): Change history

  • Description of update: To update sections 4.1, 4.2, 4.4, 4.5, 4.8, 5.1, 5.2 of the SmPC and section 1, 2 of the leaflet in-line with the information of the reference product, Noxafil 100 mg gastro-resistant tablets; MA Number: PLGB 53095/0042; MAH: Merck Sharp & Dohme (UK) Limited). In addition, editorial changes have been made in sections 2, 4 of PIL in-line with the reference product.

    Date of approval: 30/09/2026

    PIL sections updated: 1, 2 and 6

    • Changes: (Updated: 05 Oct 2026)

      Description of update: To update sections 4.1, 4.2, 4.4, 4.5, 4.8, 5.1, 5.2 of the SmPC and section 1, 2 of the leaflet in-line with the information of the reference product, Noxafil 100 mg gastro-resistant tablets; MA Number: PLGB 53095/0042; MAH: Merck Sharp & Dohme (UK) Limited). In addition, editorial changes have been made in sections 2, 4 of PIL in-line with the reference product.

      Date of approval: 30/09/2026

      PIL sections updated: 1, 2 and 6

    • Changes: (Updated: 03 Jun 2026)

      To register the addition Accord Healthcare single member S.A., 64th Km National Road, Athens, Lamia, Schimatari,32009, Greece as an alternative site responsible for importation and batch release including batch control/testing (Physical, chemical & microbiological) of the finished product. Consequently the PIL has been updated.

    • Changes: (Updated: 09 Nov 2023)

      Description of update: New product launch. Launched in the UK: 30/10/2023.

    View product information as a: